Humans have searched for reliable migraine treatments for thousands of years. Historical remedies ranged from ancient Egyptian oils to Roman blood-letting practices. Mid-twentieth-century doctors wrongly blamed repressed emotions or feminine fragility for the condition. Medical schools long taught that expanding blood vessels caused these painful attacks.
Modern neuroscience has completely transformed our understanding of severe headaches. Medical experts now categorise migraines as complex neurological conditions. A report by health journalist Joel Snape for The Guardian reveals major recent scientific discoveries.
Understanding the four phases of an attack
Migraines stem from the activation of the trigeminovascular system. This complex network of nerves and blood vessels handles pain signals in the human brain.
The trigeminal nerve releases a specific pain-inducing chemical called CGRP. This chemical triggers severe pounding pain, light sensitivity, and nausea.
Medical professionals identify four distinct phases during a typical migraine episode.
The initial warning stage causes fatigue and unusual food cravings. Researchers emphasise that food cravings do not cause the headache. The brain changes actually trigger the craving before the physical pain starts.
Nearly 30 per cent of sufferers experience a sensory aura phase next. This phase causes temporary vision problems and facial numbness.
The main headache phase then lasts between four and seventy-two hours. The recovery stage leaves patients feeling completely exhausted for days.
New targeted medical treatments bring relief
Professor Alexandra Sinclair is a leading neurology expert at the University of Birmingham. She serves as the chair of the British Association for the Study of Headache.
She explains that migraines were once useful for human survival.
The condition made early humans hyper-aware of environmental dangers. However, modern lifestyles in bright offices make the condition highly disabling.
The World Health Organization ranks migraine among the top ten most disabling conditions globally. Women suffer from these painful episodes twice as often as men.
Scientific research has introduced revolutionary new medical treatments over the past five years. Blockbuster drugs called Gepants now actively block CGRP receptors in tablet form.
Patients can also receive monthly injections of targeted antibodies. These modern medications offer effective relief for long-term sufferers.
However, access to these new treatments remains limited across the United Kingdom.
Experts urge healthcare systems to simplify the prescribing process quickly. Proper medical care allows sufferers to maintain their normal working lives.